Ignite Creation Date:
2025-12-26 @ 10:17 PM
Ignite Modification Date:
2026-03-04 @ 1:24 PM
Study NCT ID:
NCT00564512
Status:
COMPLETED
Last Update Posted:
2013-07-25
First Post:
2007-11-27
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Fludarabine, Cyclophosphamide, and Rituximab or Alemtuzumab in Treating CLL2007 CLL 2007 FMP
Sponsor:
French Innovative Leukemia Organisation